The global lateral flow assay market was valued at $8,351.30 million in 2020 and is projected to reach $13,352.90 million by 2030 registering a CAGR of 4.70% from 2021 to 2030.
A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Collateral Ligament (MCL), and Lateral Collateral Ligament (LCL). The cruciate ligaments, i.e., the PCL and ACL are crossed ligaments that stabilize the joint while allowing a very large range of motion. Knee injuries are usually the most common musculoskeletal traumas among people, where the Anterior Cruciate Ligament (ACL) injury is one of the utmost frequent occurring knee injuries. Surgical reconstruction is the standard gold treatment for treating knee injuries. Increasing incidences of sports-related injuries have become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure the ACLs disabling complete stretching of their legs.
Chinese economic development has been a significant factor in determining the shift of Chinese families to In-Vitro fertilization (IVF) when it comes to parenthood. The introduction of China's two-child policy in October 2015, Chinese women's desire to have the opportunity to focus on their careers first and later in their lives on pregnancy, or to have a child even as single parents, are all key factors behind the growing demand for IVF services in China. China In Vitro Fertilization market is expected to be more than US$ 2.8 Billion by 2025.
Market Analysis The global amyotrophic lateral sclerosis market is anticipated to touch USD 841.6 million at a healthy 7.89% CAGR during the forecast period (2018 2023). ALS or Amyotrophic Lateral Sclerosis is a neurological ailment which affects the nerve cells in the spinal cord and the brain that controls the voluntary muscles’ activities. Some of the common symptoms of ALS include cramps, muscle weakness, respiratory problems, and fasciculation. This is a progressive neurological disease where gradually patients become dependent on physicians and caregivers increasingly. Often ALS results in respiratory failure as the patient loses the ability of controlling the muscles both in the diaphragm and the chest. Ultimately, it turns fatal.
The global Amyotrophic Lateral Sclerosis (ALS) market is majorly driven by the high prevalence of Amyotrophic Lateral Sclerosis (ALS) globally and emergence of drugs treating complication associated with Amyotrophic Lateral Sclerosis (ALS) diseases. In addition, increases in strategic alliances such as geographical alliances and granting the designation such as orphan drug designation is some of the impacting factors that drives the market growth. Nevertheless, insufficient trained expertise or technically skilled professionals coupled with high treatment cost significantly hinder the growth of this market.
Global Amyotrophic Lateral Sclerosis (ALS) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
Global Amyotrophic Lateral Sclerosis (ALS) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients. For more mail: info@azothanalytics.com
Bharat Book Presents"Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff" analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal trends in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD).
Allergic Conjunctivitis Market will be US$ 2,783.5 Million by 2027. Treated Patients By Countries, Disease Type, Drugs Profile, Companies, Growth Drivers, Challenges, & Global Forecast.
According to a revised report published by Persistence Market Research, the global scar treatment market valued at US$ 16.7 Bn in 2020, and is predicted to expand at a CAGR of around 3.4% over the forecast period (2021–2031).
Amyotrophic Lateral Sclerosis (ALS) is also known as Lou Gehrig's disease is a rare and progressive neurological condition belongs to the heterogenous group of motor neurons disorders that affects mainly the motor neurons which controls the voluntary muscles.
According to a revised report published by Persistence Market Research, the global scar treatment market valued at US$ 16.7 Bn in 2020, and is predicted to expand at a CAGR of around 3.4% over the forecast period (2021–2031).
The global rheumatoid arthritis treatment market is estimated to be valued at US$ 40.5 Bn in 2021, and is expected to exhibit a CAGR of around 6% over the forecast period (2021 – 2031).
According to a revised report published by Persistence Market Research, the global scar treatment market valued at US$ 16.7 Bn in 2020, and is predicted to expand at a CAGR of around 3.4% over the forecast period (2021–2031).
Neurosyphilis Market information, by type (asymptomatic neurosyphilis, meningeal neurosyphilis, and others), diagnosis (asymptomatic neurosyphilis, meningeal neurosyphilis), by treatment (antibiotic penicillin), by end user- global forecast till 2023
Fertility services are defined as services that can help both men and women to overcome medical problems, which prevent them from having children. A new report on the global Fertilizer Service Company published by Market Research Future (MRFR), observes that this market could find growth at 6.50% CAGR between 2020 and 2027. The prominent market enhancing factors for the global fertility services market include growing urbanization, rising numbers of women joining the workforce, the inclination of women for advanced studies, delayed family planning, and reimbursement schemes. Another crucial fa
Spinal fusion is surgery to permanently join together two or more bones in the spine so there is no movement between them. For patients who require spinal fusion surgery to treat lumbar degenerative disc disease (DDD), spinal fusion device is a treatment option. Check complete report @ http://www.marketintelreports.com/report/glfr712/united-states-spinal-fusion-market-by-manufacturers-type-and-application-forecast-to-2021
The “Global Dermatology Devices Market Analysis to 2025” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global dermatology devices market with detailed market segmentation by product, application, end user and geography. The global dermatology devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Big Market Research presents a report on "Rehabilitation Robots, Active Prostheses, and Exoskeletons Market Shares, Strategies, and Forecasts, Worldwide, 2014 to 2020" Download The Full Report On : http://www.bigmarketresearch.com/rehabilitation-robots-active-prostheses-and-exoskeletons-shares-strategies-and-forecasts-worldwide-2014-to-2020-market Rehabilitation robot market size at $43.3 million is expected grow dramatically to reach $1.8 billion by 2020. Market growth is a result of the effectiveness of robotic treatment of muscle difficulty. The usefulness of the rehabilitation robots is increasing.
Global Treatment for Syndromes of Dementia and Movement Disorders Market is estimated to reach $28.6 Billion by 2024; growing at a CAGR of 8.9% from 2016 to 2024. Dementia is basically an assortment of symptoms triggered by disorders affecting the brain.
MarketReportsOnline.com adds Proton Therapy Market in Switzerland, Reimbursement Policy, Patients Treated at Proton Facility & Forecast research report of 49 pages on the proton therapy industry to the medical devices intelligence collection of its research store at http://www.marketreportsonline.com/contacts/purchase.php?name=576703.
Huntington’s disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer’s disease and Parkinson’s disease which have a high degree of prevalence. Read more details at: http://www.bigmarketresearch.com/global-neurodegenerative-diseases-2015-2019-market Analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019. Covered in this report This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases.
Big Market Research “Global Neurodegenerative Diseases Market 2015-2019” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-neurodegenerative-diseases-2015-2019-market Global Neurodegenerative Diseases Market 2015-2019, report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases.
An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.
More Information @ https://bit.ly/2huwYqa Asia Pacific calcium nitrate market will be growing with maximum CAGR over the forecast timeframe 2018 – 2025. Fertigation grade calcium nitrate market will be expanding with a prominent CAGR during the forecast period. Fertigation is the process of supplying fertilizers and other nutrients to the crops in irrigation water. Fertigation grade calcium nitrate has high content calcium and helps in improving calcium deficiency of crops.
Tennis elbow or lateral epicondylitis is a condition where the outer part of the elbow becomes painful and tender, usually as a result of repeated strain, overuse, or trauma to the region.
Tennis elbow or lateral epicondylitis is a condition where the outer part of the elbow becomes painful and tender, usually as a result of repeated strain, overuse, or trauma to the region.
Get Sample Brochure of Report @ http://www.marketintelreports.com/pdfdownload.php?id=hcr%200098 Americas is the dominant market for Spinal Surgical Robots and is estimated to reach $189.4m by 2021, growing at a CAGR of 14.2% during 2016-2021. Increased demand for minimally invasive treatment and rising investments coupled with health institutes’ support has put the American market in the top position. Growing adoption of in emerging economies like India and China strengthens the market growth in APAC region.
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period.
Platelet Rich Plasma (PRP) Treatment is beneficial for joint, ligament, tendon pain, injuries and arthritis wear, and tear. Patient’s own blood Growth Factors and Stem Cells can help to expedite the healing of the injured areas. https://goo.gl/oL9gzY
Global Orthopedic Soft Tissue Repair Market is expected to reach USD 10,675.18 million by 2024 from USD 6,167.25 million in 2016, at a CAGR of 7.2%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. For more mail: vikas@konceptanalytics.com
Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense ribonucleic acid (RNA) pneumovirus belonging to the family of Paramyxoviridae. The virus was discovered in 1956, first as an isolate from a laboratory chimpanzee displaying symptoms of the common cold, and later from infants suffering from respiratory disease.
The Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects. For information visit - https://www.aarkstore.com/pharmaceuticals-healthcare/1842808/amyotrophic-lateral-sclerosis-pipeline-review-h2
Phototherapy equipment makes use of light at different wavelengths that have proven to be effective in the treatment of medical conditions such as skin diseases as well as neonatal jaundice. The phototherapy involves exposing the skin with multiple wavelengths of light with the help of light emitting diode (LED). Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00006533
Big Market Research, Global Rehabilitation Robots Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. Big Market Research added a new research report "Rehabilitation Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2015-2021". Rehabilitation robot market size at $203.3 million in 2014 is expected grow dramatically to reach $1.1 billion by 2021. Robotic rehabilitation equipment is mostly used in rehabilitation clinical facilities. There is a huge opportunity for launching a homecare equipment market if it is done through sports clubs rather than through clinical facilities.
Big Market Research, Global Pharma Point Colorectal Cancer Drug Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems. By 2023, the end of the forecast period, GlobalData projects CRC sales to rise to $8.11 billion in the 8MM, at a moderate Compound Annual Growth Rate (CAGR) of 4.9%. Major drivers of the growth of the CRC market over the forecast period include increasing CRC incident cases, the launch of premium-priced adjuvant and maintenance treatments for first-line metastatic disease, and the launch of pipeline agents for later-line CRC. Annualized Colorectal cancer therapeutics market revenue, annual cost of therapy, and treatment usage patterns in eight patient segments, forecast from 2013 to 2023.
Exoskeleton market will be separate and additive to the robotic rehabilitation market. The exoskeleton robot market size at $16.5 million in 2014 is expected grow dramatically to reach $2.1 billion by 2021. Big Market Research, Worldwide Exoskeletons Market Size, Share, Strategies, Trends, Forecast, Demand, Industry Analysis, Research, Report, Opportunities.
Big Market Research, Global PharmaPoint HER2-Positive Breast Cancer Drug Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and fourth-line metastatic. This report forecasts that the two monoclonal antibodies that also target the HER2 receptor will ensure Roche still occupies over 95% of the market in 2023. The challenge for new entrants into the HER2-positive market is to find patient populations that are currently underserved, and can work cooperatively with Roche’s targeted therapies.
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period. Gain More Insight: https://bit.ly/3wWI0do Get Sample Report: https://bit.ly/3ltFdo6 Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
The market for preterm birth control is expected to grow due to rising number of preterm births across the globe as well as increasing number of initiatives undertaken by government and private bodies to promote the use of preterm birth control therapeutics and devices. In addition, growth of pharmaceutical and medical device research and development as well as increasing healthcare expenditure of emerging nations are likely to have a positive impact on the growth of the preterm birth control market in the coming years.
The market for preterm birth control is expected to grow due to rising number of preterm births across the globe as well as increasing number of initiatives undertaken by government and private bodies to promote the use of preterm birth control therapeutics and devices. In addition, growth of pharmaceutical and medical device research and development as well as increasing healthcare expenditure of emerging nations are likely to have a positive impact on the growth of the preterm birth control market in the coming years.
This report provides a wide-ranging study of global Wilson’s disease market and also its key regional markets. For more mail: vikas@konceptanalytics.com
The rising incidence rate of life-threatening diseases, developments in certification for palliative care, and the increasing number of geriatric population have resulted in boosting the Palliative Care market.
For more Info: https://www.renub.com/global-car-t-cell-therapy-market-nd.php Renub Research recent report on CAR T Cell Therapy Market, anticipate that it will grow at with a CAGR of almost 50% over the period of 2018-2028. Over some years, immunotherapy has emerged as one of the most curative ways in the treatment of cancerous tumors among the cancer community which strengthen the power of patient’s immune system to fight these tumors. Immunotherapy; adoptive cell transfer (ACT) for cancer treatment is evolving very rapidly adoptive cell transfer (ACT) which includes collection and usage of patient’s own immune cells in the treatment of their cancer. There are various types of adoptive cell transfer (ACT) are being developed namely; TILs, TCRs, and CARs, of which, CARs- CAR T-cell therapy is the only clinical developed advanced approach used in the treatment of cancer.
“Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” is a cutting-edge comprehensive report on the personalized medicine industry and its impact on the health system. This report tackles the growing market interest in pharmacogenomics, companion diagnostics and the associated market environment. See Full Report : http://bit.ly/1xTcMmO
The report is an essential source of information and analysis on the global Narcolepsy Therapeutics market. The report identifies the key trends shaping and driving the global Narcolepsy Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. For more information : http://bit.ly/1wDZ3NU
Get a detailed report at http://www.marketoptimizer.org/stalevocomtan-parkinsons-disease-forecast-and-market-analysis-to-2022.html . Comtan (entacapone) was developed by Orion for Parkinson’s disease patients who experience end-of-dose wearing-off. The product, known as Comtan, is co-marketed with Novartis across the US, certain European markets, Brazil, and Japan. Orion has exclusive rights to the Nordic and Baltic countries, where the company is based, the UK, Ireland, and Germany, and is known as Comtess in these markets. Comtan/Comtess was first approved and launched in Europe in 1998, and launched a year later in the US. Additionally, entacapone is one of the active ingredients in Stalevo, a triple-combination pill with carbidopa, levodopa, and entacapone, co-marketed with Novartis.